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Abstract - Myelin oligodendrocyte glycoprotein (MOG) is а protein widely used in the induction of experimental autoim-
mune encephalomyelitis (EAE) for studying human multiple sclerosis (MS). In C57BL/6 female mice aged eight weeks, 
we administered subcutaneously MOG35-55 peptide in CFA (complete Freund’s adjuvant) along with pertussis vaccine 
injected intraperitoneally. We observed the sign of flaccid tail as early as thirteen days post-immunization in five of twelve 
animals. Hematoxylin and eosin staining of paraffin-embedded sections of lymph nodes and spleen revealed the presence 
of germinal centers in the immunized animals. In the control group of animals, lymphoid follicles without germinal cen-
ters were observed. Immunohistochemical staining of spleen sections revealed an expression of MHC II molecules in the 
EAE-induced group. We would like to point out that even though the clinical signs are mild, the morphological changes 
are apparent in the lymph nodes and spleen of MOG35-55-immunized mice.
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INTRODUCTION
The immune system is functionally compartmental-
ized into primary lymphoid organs responsible for 
the generation and differentiation of naive T and B 
cells, and secondary lymphoid organs where immune 
responses are initiated. Only after activation do T and 
B cells emigrate from secondary lymphoid organs to 
seek the antigen in the periphery. Secondary lym-
phoid organs include the spleen, lymph nodes and 
organized lymphoid tissues associated with mucosal 
membranes such as the tonsils, appendix, and Peyer’s 
patches. These highly organized secondary lymphoid 
organs provide the structures where the antigen is ef-
ficiently retained and presented and where ordered 
cellular interactions between antigen presenting cells 
(APCs), T cells and B cells take place to initiate and 
promote efficient immune responses (Karrer et al., 
1997, Abbas et al., 1997).
Experimental autoimmune encephalomyelitis 
(EAE) is an animal model that recapitulates many 
clinical and pathological features of human multiple 
sclerosis (Batoulis et al., 2011, Stojkov et al., 2006). 
EAE induced by immunizing C57BL/6 mice with 
myelin oligodendrocyte glycoprotein (MOG) pep-
tide 35-55 is particularly useful because, like MS, 
it results in inflammation, demyelination and axon 
loss, primarily in the spinal cord (Jones et al., 2008; 
Costa et al., 2003). Neuronal death and gray matter 
atrophy was documented in mice with EAE (Mac-
Kenzie-Graham et al., 2006). Severe exacerbation 
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was found in mice with abated overall expression of 
MHC II molecules by plasmacytoid dendritic cells 
previously immunized with myelin oligodendrocyte 
glycoprotein (Irla et al., 2010).
We examined the morphological changes in 
lymph nodes and spleen tissue and the expression 
of MHCII molecules in sections of the spleen of 
C57BL/6 mice with EAE induced by MOG35-55.
MATERIALS AND METHODS
Animals
Female C57BL/6 8-week-old mice were purchased 
from the Military Medical Academy (Serbia). The 
mice were kept under standard laboratory conditions 
(room temperature 21±1°C, humidity 30%, 12/12 h 
light/dark cycle) with food and tap water ad libitum. 
The protocols for the animal experiment were con-
ducted in accordance with the guidelines (86/609/
EEC) of the European Community Council Direc-
tives and the Serbian Laboratory Animal Science As-
sociation – SLASA. The study was performed on 19 
mice divided in two groups: EAE-induced (mice im-
munized with MOG in CFA; n=12) and an IC group 
(non-treated animals; n=7).
EAE induction
C57BL/6 mice were injected subcutaneously in the 
right side of the flank with 100 µg of myelin oli-
godendrocyte glycoprotein peptide (MOG35-55, Sigma 
Aldrich) in complete Freund’s adjuvant (CFA) con-
taining 1 mg/ml of heat-killed and dried Mycobacte-
rium tuberculosis H37Ra (Sigma Aldrich) according 
to Suter et al. (2000). 1x109 of heat-killed Bordetella 
pertussis bacilli in 150 µl of PBS (pertussis vaccine, 
Institute of Virology, Vaccine and Sera “Torlak”) was 
injected intraperitoneally on the day of immuniza-
tion and 48 h later. 
Development of the clinical signs of EAE in the 
mice was monitored daily, starting at day 7 post im-
munization according to the following criteria: (0), 
no clinical signs; (1) flaccid tail; (2) hind leg paresis; 
(3) full hind leg paralysis; (4) quadriplegia; (5) death. 
The mice were sacrificed on day 24 after immuniza-
tion. Over this period of time the mice showed the 
flaccid tail sign that was less severe than typically ob-
served, and were scored as 0.5 less than the indicated 
grade. 
Tissue collection
All mice were placed under deep anesthesia, and 
then cardially perfused with PBS pH 7.4 followed 
by 4% PFA (paraformaldehyde) in 0.1 M phosphate 
buffer. The organs were preserved in 4% formalde-
hyde for later histological and immunohistochemical 
examination. Formalin-fixed paraffin-embedded tis-
sue was cut to 5-μm thick sections of the spleen and 
lymph nodes by a microtome (Microtome HM 450; 
Leica). The sections of each experimental group were 
then stained with hematoxylin and eosin to visualize 
cell morphology in the tissue sections. 
Immunohistochemistry
Paraffin-embedded sections of the spleen (5 μm thick) 
were harvested onto superfrost slides (ThermoScien-
tific, Menzel, Braunschweig, Germany), deparaffi-
nized in xylene and rehydrated in graded series of 
alcohols (2x100% 5min, 1x96% 5min, 1x70% 5min). 
Antigen retrieval was performed by the heat-induced 
microwave retrieval method, using citrate buffer pH 
6. The slides were washed three times in TBS (Tris 
Buffer saline) and then incubated with 0.3% H2O2 in 
methanol to quench endogenous peroxidase activity. 
Followed by a series of washes (3× PBS pH 7.4), the 
sections were then blocked with 10% normal rabbit 
serum. The sections were incubated for 1 h at room 
temperature or overnight at +4°C in a humidified 
chamber with a primary anti-MHC class II antibody 
(1:50 anti-mouse MHC II; AbD Serotec, Oxford, 
UK). After three washes with TBS, the sections were 
incubated with peroxidase-labeled rabbit anti-mouse 
IgG (DAKO, Glostrup, Denmark) (1:1000) for 1 h 
at room temperature. Subsequently, all slides were 
rinsed in distilled water, counterstained with he-
matoxylin, dehydrated in graded series of alcohols, 
mounted and cover-slipped.
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Tissue analysis
The analysis of tissue sections was performed by 
capturing images of sections using a BH2 research 
microscope (Olympus Optical Co. LTD. Tokyo, Ja-
pan) equipped with a Color View III digital camera 
(Olympus). Analysis Docu software (Olympus) was 
used to acquire images. All images were taken under 
10x and 40x magnification.
RESULTS AND DISCUSSION
Clinical signs of EAE in C57BL/6 mice
All immunized animals were monitored for clinical 
signs of EAE development, starting at day 7 post-
Fig. 1.Hematoxylin and eosin staining of the lymph node. Lymph node cortex of EAE-induced group and control group (photomi-
croscopic images) (Fig. 1A, Fig. 1B). The germinal center of EAE-induced group and lymphoid follicles of control group is marked by 
arrows. Magnification x10.
Fig. 2 Hematoxylin and eosin staining of spleen sections. Spleen white pulp of EAE-induced group and control group (photomicro-
scopic images) (Fig. 2A, Fig. 2B). The enlarged follicle of EAE-induced group with germinal center is marked by vertical white arrow. 
The follicle without germinal center of the control group is marked by a horizontal white arrow. Magnification x10.
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MOG immunization. A clinical sign such as a flaccid 
tail was observed in 5 of 12 animals on day 13 after 
immunization. Aggravation of clinical signs was not 
observed on day 24 post immunization when the an-
imals were killed. We further performed histological 
analysis of the lymph nodes and spleen, and immu-
nohistochemical staining of the MHC II antigen in 
the sections of the spleen.
Presence of germinal centers in the lymph nodes and 
spleen in C57BL/6 mice
In the lymph nodes and spleen of both immunized 
and control groups, lymphoid follicles – B cell areas 
along with T cells located predominantly between the 
follicles, were observed. Histological examination of 
the lymph nodes and spleen from the EAE-induced 
mice showed an increased number of pyroninophilic 
cells in the germinal centers of the lymphoid follicles 
(Fig. 1A, Fig. 2A). T and B cell response to subcuta-
neously introduced MOG35-55 peptide may trigger a 
cascade of events leading to germinal center forma-
tion. Germinal centers that develop in response to 
antigen stimulation are the sites of B cell clonal ex-
pansion. They are functionally polarized into a dark 
zone in which the B cells divide and a light zone in 
which the B cells are activated, and selected based on 
their affinity for the antigen (Victora and Nussenz-
weig, 2012). In the non-treated group, the presence 
of lymphoid follicles without germinal centers in the 
lymph nodes and spleen was observed (Fig. 1B, Fig. 
2B). Histological analysis of the spleen showed vis-
ible changes in the lymphoid follicle of the spleen 
white pulp in the MOG35-55-immunized mice (Fig. 
2A). The white pulp of the spleen consists of T cell 
areas and B cell follicles resembling the organization 
of the lymph nodes. This structure is considered one 
of the most important inductive sites of the immune 
system, where trafficking and interactions among 
dendritic cells, T cells and B cells take place upon 
antigen challenge (Mebius and Kraal, 2005). We ob-
served a positive correlation between the presence of 
germinal centers in the lymph nodes and spleen and 
circulating anti-MOG antibodies in the sera of the 
EAE-induced mice (unpublished results).
MHCII molecules with significantly higher expression 
in spleen sections of EAE-induced animals
A significantly higher expression of MHC II mol-
ecules was detected in the sections of the spleen 
from the animals immunized with MOG35-55 peptide 
(Fig. 3A). The sections from the control group (IC) 
showed a lower expression of MHC class II mol-
ecules (Fig. 3B). MHC II molecules play a crucial 
role in the regulation and induction of immune re-
Fig. 3 Immunohistochemical staining of MHC II molecules in spleen sections. EAE-induced group and control group (photomicro-
scopic images) (Fig. 3A, Fig. 3B). MHC II expression in both groups is marked by arrows. Magnification x40.
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sponse. Constitutive MHC II expression is the hall-
mark of three distinct types of cells, dendritic cells, 
B cells and the cells of monocyte/macrophage line-
age (Waldburger et al., 2001). Efficient priming of 
naive T lymphocytes requires both the presentation 
of an antigen in the context of MHC molecules and 
the delivery of accessory signals provided by antigen 
presenting cells (APCs), such as dendritic cells (DC) 
(Muraille et al., 2002).
Dendritic cells (DCs) play well-established roles 
in the induction of immunity and tolerance. Both 
functions require antigen (Ag)-specific interactions 
between T cells and DCs in the secondary lymphoid 
tissues. The outcome of these interactions depends 
on the modulation and integration of three signals: 
T cell receptor engagement by peptide-MHC com-
plexes, the recruitment of costimulatory and adhe-
sion molecules, and the delivery of soluble mediators 
(Lebedeva et al., 2005). Signals associated with in-
flammation, infections or tissue damage induce DC 
maturation, a process involving complex phenotypi-
cal changes, including the upregulation of MHCII, 
costimulatory and adhesion molecules, the secretion 
of inflammatory mediators and altered migratory 
properties. Activation of naive T cells by mature DCs 
results in clonal expansion and differentiation into 
effector and memory T cells (Irla et al., 2010). 
Plasmacytoid DCs (pDCs) constitute a unique 
dendritic cell subtype. They circulate in the blood and 
access secondary lymphoid organs from the blood, 
driven mainly by inflammatory stimuli. It is suggest-
ed that they take part in both innate and adaptive im-
munity (Colonna et al., 2004). However, pDCs also 
express MHCII molecules and undergo a maturation 
process similar to that of conventional DCs (Villa-
dangos and Young, 2008). Furthermore, pDCs can 
internalize, process and present antigens to CD4+ T 
cells and cross-present antigens to CD8+T cells (Ho-
effel et al., 2007; Sapoznikov et al., 2007; Di Pucchio 
et al., 2008; Young et al., 2008). These findings have 
suggested that pDCs can function as APCs.
EAE induced by immunization with myelin 
oligodendrocyte glycoprotein (MOG) was found to 
be severely exacerbated in mice exhibiting a selec-
tive abrogation of MHCII expression by pDCs. EAE 
induction triggered the recruitment of pDCs to the 
lymph nodes, where they engaged in MHCII-de-
pendent and MOG-specific interactions with CD4+ 
T cells. It was suggested that MHCII expression by 
pDCs confers protection against EAE by inhibiting 
the priming of encephalitogenic T cells in second-
ary lymphoid tissues but has no evident impact on 
the subsequent effector phase in the CNS (Irla et al., 
2010).
MHC class II antigen positive cells, apparent in 
the sections of the spleen, might render a link between 
the mild clinical signs expressed in EAE-induced 
mice and the expression of MHCII molecules. 
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